“Today there is a meeting of the Committee for Medicinal Products for Human Use (CHMP) of the EMA to discuss the Moderna vaccine”, the Amsterdam-based European regulator said in a statement.
A new press release could be published during the day “In case the CHMP comes to a decision during today’s meeting”. Otherwise, the Committee would meet again on Wednesday.
The EMA authorized on December 21 the vaccine against the Covid-19 Pfizer / BioNTech, for which the European Commission immediately gave the green light, and was to pronounce on January 6 on that of Moderna.
The Moderna vaccine is taken in two doses, a few weeks apart, like the Pfizer / BioNTech vaccine. But Moderna’s formula can be stored at -20ºC, and not -70ºC as with Pfizer’s remedy, which forced the group to develop specific containers for transport.
The American Medicines Agency (FDA) announced on December 18 that it had granted this American laboratory an emergency authorization, a week after having done the same with that of Pfizer and BioNTech.
The EMA headquarters moved from London to Amsterdam as a consequence of Brexit.